943917-47-3

Basic information

• Product Name: (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5'-bromo-2'-fluoro-4-(trifluoromethyl)-biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one
• Synonyms: (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5'-bromo-2'-fluoro-4-(trifluoromethyl)-biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one
• CAS NO: 943917-47-3
• Molecular Weight: 644.307
• Mol File: 943917-47-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5'-bromo-2'-fluoro-4-(trifluoromethyl)-biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5'-bromo-2'-fluoro-4-(trifluoromethyl)-biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one(943917-47-3)
• EPA Substance Registry System: (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5'-bromo-2'-fluoro-4-(trifluoromethyl)-biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one(943917-47-3)

Safety Data

• Hazardous Substances Data: 943917-47-3(Hazardous Substances Data)

Upstream product

• 875446-35-8 (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-iodo-5-(trifluoromethyl)benzyl]-4-methyl-1,3-oxazolidin-2-one 
• 112204-57-6 dihydroxy-(5-bromo-2-fluorophenyl)-borane 
• 163444-17-5 2-iodo-4-(trifluoromethyl)aniline 
• 6526-08-5 2-amino-5-(trifluoromethyl)benzonitrile 
• 875444-08-9 (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one 
• 868166-20-5 2-iodo-5-(trifluoromethyl)benzonitrile 
• 702641-05-2 [2-iodo-5-(trifluoromethyl)phenyl]methanol 
• 702641-06-3 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene 
• 702641-04-1 2-iodo-5-(trifluoromethyl)benzoic acid 
• 871917-79-2 benzyl {(1S)-2-[3,5-bis(trifluoromethyl)phenyl]-1-methyl-2-oxoethyl}carbamate 

Relevant articles and documents

CETP INHIBITORS

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B.